Cerenome, Inc. (CNSY)
0.5698
-0.07
(-11.34%)
USD |
NASDAQ |
Nov 09, 16:00
0.5678
0.00 (0.00%)
Pre-Market: 09:21
Cerenome Cash and Short Term Investments (Quarterly) : 8.587M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.587M |
| March 31, 2026 | 15.11M |
| December 31, 2025 | 13.11M |
| September 30, 2025 | 16.60M |
| June 30, 2025 | 6.879M |
| March 31, 2025 | 9.867M |
| December 31, 2024 | 3.606M |
| September 30, 2024 | 4.788M |
| June 30, 2024 | 8.435M |
| March 31, 2024 | 3.224M |
| December 31, 2023 | 8.554M |
| September 30, 2023 | 11.01M |
| June 30, 2023 | 10.90M |
| March 31, 2023 | 12.72M |
| December 31, 2022 | 18.12M |
| September 30, 2022 | 20.27M |
| June 30, 2022 | 18.09M |
| March 31, 2022 | 21.24M |
| December 31, 2021 | 18.40M |
| September 30, 2021 | 21.28M |
| June 30, 2021 | 17.16M |
| March 31, 2021 | 14.45M |
| December 31, 2020 | 8.346M |
| September 30, 2020 | 7.626M |
| June 30, 2020 | 9.266M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.06M |
| December 31, 2019 | 17.59M |
| September 30, 2019 | 16.87M |
| June 30, 2019 | 4.57M |
| March 31, 2019 | 3.912M |
| December 31, 2018 | 5.301M |
| September 30, 2018 | 6.846M |
| June 30, 2018 | 3.119M |
| March 31, 2018 | 5.942M |
| December 31, 2017 | 10.22M |
| September 30, 2017 | 5.212M |
| June 30, 2017 | 9.457M |
| March 31, 2017 | 6.605M |
| December 31, 2016 | 12.91M |
| September 30, 2016 | 14.92M |
| June 30, 2016 | 20.04M |
| March 31, 2016 | 9.358M |
| December 31, 2015 | 14.34M |
| September 30, 2015 | 18.97M |
| June 30, 2015 | 23.84M |
| March 31, 2015 | 13.20M |
| December 31, 2014 | 14.62M |
| September 30, 2014 | 7.849M |
| June 30, 2014 | 12.76M |
| March 31, 2014 | 12.80M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.587B |
| Ernexa Therapeutics, Inc. | 5.575M |
| ACADIA Pharmaceuticals, Inc. | 976.45M |
| Anika Therapeutics, Inc. | 44.96M |
| Savara, Inc. | 173.03M |